# Eli Lilly and Company (LLY) — Q4-2024 Earnings Results

**Report date:** 2025-02-06 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q4-2024

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Up 3.35%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $5.32 | N/A | +5.77% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering innovative treatments.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Eli Lilly's strong EPS performance indicates effective cost management and possibly strong demand for its products. The stock's 3.35% increase reflects investor confidence in the company's ability to generate profits. However, the lack of revenue details and future guidance may leave some investors cautious.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q4-2024_